Burnasyan Federal Medical Biophysical Center Report issue

Government Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02145923
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Burnasyan Federal Medical Biophysical Center | Burnasyan FMBC SRC FMBA of Russia | FGBUZ MSCH-163, FMBA of Russia